

Colgate-Palmolive vs Diageo
Global oral care and household products leader vs Global alcoholic beverage producer with strong premium brands. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Colgate-Palmolive sells toothpaste, soap, and pet food to consumers across every income level in nearly every country on earth, generating steady if unspectacular organic growth, while Diageo distributes Johnnie Walker, Guinness, and a portfolio of premium spirits that depend on consumers trading up in good times and trading down sharply when economies weaken. Both companies are consumer staples stalwarts with strong brand portfolios and international revenue exposure to emerging market currencies. Colgate-Palmolive vs Diageo examines how daily necessity purchasing compares with discretionary premiumization as a foundation for consistent long-term earnings growth.
Colgate-Palmolive sells toothpaste, soap, and pet food to consumers across every income level in nearly every country on earth, generating steady if unspectacular organic growth, while Diageo distribu...
Why It’s Moving

Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.

DEO is trading on renewed analyst optimism as investors look past near-term softness toward a recovery story.
- Analyst sentiment stayed constructive, with several forecast trackers showing double-digit upside expectations for Diageo, suggesting investors are still pricing in a rebound rather than a reset in the business.
- The gap between forecast ranges and the current share price points to expectations for improving operating momentum, even though the consensus view remains mixed rather than outright bullish.
- With no major company-specific catalyst in the last week, the stock is moving more on broader analyst reassessment of premium spirits demand, margin recovery, and normalization in consumer spending than on a fresh earnings surprise.

Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.

DEO is trading on renewed analyst optimism as investors look past near-term softness toward a recovery story.
- Analyst sentiment stayed constructive, with several forecast trackers showing double-digit upside expectations for Diageo, suggesting investors are still pricing in a rebound rather than a reset in the business.
- The gap between forecast ranges and the current share price points to expectations for improving operating momentum, even though the consensus view remains mixed rather than outright bullish.
- With no major company-specific catalyst in the last week, the stock is moving more on broader analyst reassessment of premium spirits demand, margin recovery, and normalization in consumer spending than on a fresh earnings surprise.
Investment Analysis
Pros
- Colgate-Palmolive maintains a globally dominant position in oral care, with over 40% global toothpaste market share and leading brands across personal and home care categories.
- The company consistently generates stable revenue growth, recently posting a 3.3% year-on-year increase, supported by resilient demand for essential consumer products.
- Colgate-Palmolive offers a reliable dividend yield near 2.7%, appealing to income-focused investors, and has a long track record of returning capital to shareholders.
Considerations
- Colgate-Palmolive’s growth has been modest compared to peers, with limited share price appreciation over the past year and a premium valuation reflected in a P/E above 21.
- The company carries a relatively high debt-to-equity ratio, raising potential concerns about financial leverage and risk in a rising interest rate environment.
- Colgate-Palmolive faces intensifying competition in core markets, particularly from nimble private-label and digital-native brands eroding traditional market share.

Diageo
DEO
Pros
- Diageo benefits from a diverse portfolio of premium spirits brands and a broad global distribution footprint, enabling resilience across different geographies and economic cycles.
- The company has demonstrated pricing power and the ability to expand margins through premiumisation trends, particularly in growing categories like whisky and tequila.
- Diageo’s innovation pipeline in ready-to-drink and non-alcoholic beverages positions it to capitalise on shifting consumer preferences and expanding addressable markets.
Considerations
- Diageo’s performance is exposed to macroeconomic headwinds, as premium spirit demand can soften during economic downturns or periods of reduced discretionary spending.
- Regulatory pressures, including increased alcohol taxes and stricter marketing restrictions, present ongoing risks across Diageo’s key markets in the Americas and Asia.
- Supply chain disruptions and rising input costs, particularly for agri-commodities like barley and glass, could pressure Diageo’s profitability in the near term.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Diageo (DEO) Next Earnings Date
The next earnings date for DEO is expected to be August 6, 2026, before the market opens. It should cover fiscal Q4 2026 for Diageo, based on the company’s reporting cycle. If the date shifts, it would typically still fall in early August given the stock’s historical earnings pattern.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Diageo (DEO) Next Earnings Date
The next earnings date for DEO is expected to be August 6, 2026, before the market opens. It should cover fiscal Q4 2026 for Diageo, based on the company’s reporting cycle. If the date shifts, it would typically still fall in early August given the stock’s historical earnings pattern.
Buy CL or DEO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


